| Ytd | 25.95% | |
| 1y | 34.56% |
| Open | 178.87 | Prev Close | 179.05 | Low | 177.46 | High | 181.00 | Mkt Cap | 18.00B |
| Vol | 123.86K | Avg Vol | 1.20M | EPS | 6.92 | P/E | 25.87 | Forward P/E | 24.10 |
| Beta | 0.39 | Short Ratio | 4.48 | Inst. Own | 104.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 12-29 | Earning | 07-30 | 50-d Avg | 164.03 | 200-d Avg | 144.35 | 1yr Est | 200.24 |
NBIX News
SAN DIEGO, July 21, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced
Wells Fargo analyst Mohit Bansal maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Overweight
NVIDIA, Neurocrine and Ball screen well for earnings growth and rising estimates, highlighting stock
Truist Securities analyst Danielle Brill maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Bu
BMO Capital analyst Evan Seigerman maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Market P
RBC Capital analyst Brian Abrahams maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Outperfo
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced the initiation of its Phase 2 clinical st
Tom Lee's GRNJ added First Solar, Zoom and eight other stocks in its latest rebalance as assets
Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfol
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quart
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings